FEMY
Femasys IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$14.43M
P/E Ratio
—
EPS
$-4.80
Beta
-2.25
52W High
$22.20
52W Low
$4.05
50-Day MA
$7.64
200-Day MA
$11.06
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Femasys Inc
Femasys Inc. is an innovative medical technology company dedicated to transforming women's healthcare through its proprietary solutions for diagnosing and treating gynecological conditions. With a focus on non-surgical alternatives, Femasys is addressing prevalent issues such as uterine fibroids and contraception, positioning itself as a key player in the growing field of women’s health. As demand for minimally invasive treatments continues to rise, the company is strategically equipped to enhance patient outcomes and efficiency in healthcare delivery. By concentrating on significant unmet needs, Femasys aims to set new standards for care in this essential sector.
Fundamentals
| Revenue (TTM) | $2.38M |
| Gross Profit (TTM) | $1.46M |
| EBITDA | $-16.01M |
| Operating Margin | -994.00% |
| Return on Equity | -256.00% |
| Return on Assets | -68.60% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.12 |
| Price-to-Book | 1.98 |
| Price-to-Sales (TTM) | 6.07 |
| EV/Revenue | 5.8 |
| EV/EBITDA | 0.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 24.50% |
| Shares Outstanding | $3.02M |
| Float | $49.93M |
| % Insiders | 9.28% |
| % Institutions | 10.13% |
Historical Volatility
HV 10-Day
96.95%
HV 20-Day
136.22%
HV 30-Day
126.00%
HV 60-Day
109.56%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($63.33 target)
2
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026